Predictive Oncology Inc.

1.48
-0.04 (-2.63%)
At close: Apr 01, 2025, 3:59 PM
1.46
-1.35%
After-hours: Apr 01, 2025, 07:49 PM EDT

Predictive Oncology Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income -12.66M -13.98M -25.74M -19.66M -25.88M
Depreciation & Amortization 695.66K 739.32K 1.31M 1.34M 1.02M
Stock-Based Compensation n/a n/a 522.44K 921.13K 1.17M
Other Working Capital n/a -729.75K 964.82K -725.17K 468.08K
Other Non-Cash Items 994.16K 452.82K 11.19M 1.17M 13.81M
Deferred Income Tax n/a n/a -522.44K -661.66K -1.17M
Change in Working Capital n/a -397.56K 866.69K -1.19M -1.21M
Operating Cash Flow -10.97M -13.19M -12.37M -12.21M -12.26M
Capital Expenditures -9.51K -302.37K -475.7K -962.32K -360.78K
Acquisitions n/a n/a n/a -9.59M 193.32K
Purchase of Investments n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -26.02K -55.83K -55K 193.32K
Investing Cash Flow -9.51K -302.37K -475.7K -10.61M -167.46K
Debt Repayment n/a 150.41K n/a -5.24M 1.29M
Common Stock Repurchased n/a -1.51K -27.65K -11.53K n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 3.94M n/a n/a 4.39M 1.71M
Financial Cash Flow 3.94M 148.9K 6.72M 50.34M 12.95M
Net Cash Flow -7.99M -13.34M -6.13M 27.52M 527.5K
Free Cash Flow -10.98M -13.49M -12.85M -13.17M -12.62M